News
-
-
PRESS RELEASE
Kintara Therapeutics and TuHURA Biosciences Provide Update on Recent Corporate and Clinical Advancements and Outline Near Term Milestones
Kintara Therapeutics, Inc. and TuHURA Biosciences, Inc. provide overview of recent corporate and clinical advancements, with upcoming milestones including merger closing and clinical trial commencement -
-
-
-
PRESS RELEASE
Catheter Precision, Inc. (NYSE American: VTAK) Reports Preliminary Unaudited Revenue for the Second Quarter and Six Months Ended June 30, 2024
Catheter Precision, Inc. reports 15% quarter-over-quarter growth with initial sales of LockeT recorded, generating total revenue of $94,840 for Q2 ending June 30, 2024 -
-
PRESS RELEASE
CRCAM Brie Picardie – déclaration hebdomadaire – Rachats réalisés dans les conditions de l'article 5 du Règlement MAR
Caisse Régionale de Crédit Agricole Mutuel Brie Picardie réalise des rachats conformément au Règlement MAR, avec une approche agrégée et détaillée par jour et par transaction -
-
PRESS RELEASE
Pentixapharm Announces Expansion of Supervisory Board with the Appointment of Distinguished Endocrinologist Marcus Quinkler
Pentixapharm AG appoints distinguished endocrinologist Marcus Quinkler to its Supervisory Board. Quinkler's expertise in primary aldosteronism aligns with the company's focus on innovative radiopharmaceuticals
